Journals / Marmara Medical Journal / 2015 / Cilt: 28 - Sayı: 2

Relation between the expression of E-cadherin, p53,c-erb-B2 (HER-2/neu) and steroid receptors (ER, PgR) in invasive ductal breast carcinoma with axillary lymph node metastases

Aksiller lenf nodu metastazlı invaziv duktal meme karsinomda E-cadherin, p53, c-erb-B2 (HER- 2/neu) ve steroid reseptörleri (ER, PgR) ekspresyonu arasındaki ilişki

Pages
99–104
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The presence of E-cadherin was associated with axillary lymph node metastases and p53 (p<0.009, p<0.001, respectively).Conclusion: We found that, the p53 protein may play a role in regulation of E-cadherin protein expression in invasive ductal breast carcinomas with axillary lymph node metastases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study explores the correlation between the expression of E-cadherin, p53 tumor suppressor gene, c-erb-B2 (HER-2/neu) and steroid receptors (ER, PgR) in invasive ductal breast carcinoma with axillary lymph node metastases.Patients and Methods: We have investigated tumor samples from sixty patients with invasive ductal breast carcinoma. 30 of the patients had axillary lymph node metastases and 30 had no axillary lymph node metastases.
📊
Key Findings & Data:Tumor tissues of these patients were evaluated by immunohistochemistry for E-cadherin, p53, c-erb-B2 (HER-2/neu) and steroid receptors (ER, PgR).
💡
Conclusion & Impact:The presence of E-cadherin was associated with axillary lymph node metastases and p53 (p<0.009, p<0.001, respectively).Conclusion: We found that, the p53 protein may play a role in regulation of E-cadherin protein expression in invasive ductal breast carcinomas with axillary lymph node metastases.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Meme karsinomu · E-cadherin · p53

Abstract

Objective: This study explores the correlation between the expression of E-cadherin, p53 tumor suppressor gene, c-erb-B2 (HER-2/neu) and steroid receptors (ER, PgR) in invasive ductal breast carcinoma with axillary lymph node metastases.Patients and Methods: We have investigated tumor samples from sixty patients with invasive ductal breast carcinoma. 30 of the patients had axillary lymph node metastases and 30 had no axillary lymph node metastases. Tumor tissues of these patients were evaluated by immunohistochemistry for E-cadherin, p53, c-erb-B2 (HER-2/neu) and steroid receptors (ER, PgR). Results: E-cadherin staining was not expressed in 39 patients (65%) with invasive ductal breast carcinoma. ER, PgR, p53, and c-erb-B2 signals were positive in 36 (60%), 26 (43.3%), 33 (55%), and 29 (48.3%) of the patients, respectively. PgR and c-erb-B2 expression was associated with lymph node metastases (p=0.009, p=0.001, respectively). No association was found between the reduced E-cadherin protein and age. The presence of E-cadherin was associated with axillary lymph node metastases and p53 (p<0.009, p<0.001, respectively).Conclusion: We found that, the p53 protein may play a role in regulation of E-cadherin protein expression in invasive ductal breast carcinomas with axillary lymph node metastases.

Özet

Amaç: Aksiller lenf nodu metastazlı invaziv duktal meme karsinomda E-cadherin, p53 tümör supressör gen, c-erbB-2 (HER2/neu) ve steroid reseptörleri (ER ve PgR) ekspresyonu arasındaki ilişkiyi araştırmak amaçlanmıştır.Hastalar ve Yöntem: Bu çalışmada, 30 aksiller lenf nodu metastazlı ve 30 aksiller lenf nodu metastazı mevcut olmayan invaziv duktal meme karsinomlu 60 hasta immunokimyasal metodu kullanılarak E-cadherin ve c-erbB-2, ER ve PgR antikorları değerlendirildi.Bulgular: İnvaziv duktal meme karsinomlu 60 hastanın 39’unda (%65) E-cadherin ile boyanma tesbit edilmedi. Sırasıyla ER, PgR, p53, ve c-erb-B2, 60 hastanın 36’ında (%60), 60 hastanın 26’ında (%43,3), 60 hastanın 33’ünde (%55), and 60 hastanın 29’unda (%48,3) pozitif boyanma görüldü. PgR ve c-erb-B2 boyanması lenf nodu metastazı ile ilişkili idi (sırasıyla, p=0,009, p=0,001). E-cadherin proteini ile yaş arasında ilişki görülmedi. E-cadherin ile lenf nodu metastazı ve p53 arasında ilişki görüldü (sırasıyla, p

🔖

Cite This Article

KILINÇ, N. (2015). Relation between the expression of E-cadherin, p53,c-erb-B2 (HER-2/neu) and steroid receptors (ER, PgR) in invasive ductal breast carcinoma with axillary lymph node metastases. Marmara Medical Journal, Cilt: 28 - Sayı: 2, 99–104. https://ajindex.com/articles/283876

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Park D, Karesen R, Ulrika A, Noven T, Sauer T. Expression pattern of adhesion molecules (E-cadherin, alpha-, beta-, gamma-catenin and c1audin-7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis. APMIS 2007
  2. doi: 10.1111/ j.1600-0463.2007.apm_524.x 2. Kovacs A, Dhillon J, Walker R A. Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas. Mol Path 2003
  3. doi:10.1136/mp.56.6.318 3. Mohammadizadeh F, Ghasemibasir H, Rajabi P, Naimi A, Eftekhari A, Mesbah A. Correlation of E-cadherin expression and routine immunohistochemistry panel in breast invasive ductal carcinoma. Cancer Biomark 2009
  4. doi: 10.3233/ CBM-2009-0551 4. Singhai R, Patil VW, Jaiswal SR, Patil SD, Tayade MB, Patil AV. E-Cadherin as a diagnostic biomarker in breast cancer. North Am J Med Sci 2011
  5. doi.org/10.4048/ jbc.2013.16.1.16 5. Bukholm IK, Nesland JM, Karesen R, Jacobsen U, BorresenDale AL. Expression of E-cadherin and its relation to the p53 protein status in human breast carcinomas. Virchows Arch 1997
  6. doi: 10.1007/s004280050105. 6. Kilinc N, Yaldiz M. p53, c-erbB-2 expression and steroid hormone receptors in breast carcinoma: correlations with histopathological parameters. Eur J Gynaecol Oncol 2004
  7. Yao ZX, Lu LJ, Wang RJ, et al. Discordance and clinical significance of ER, PR, and HER2 status between primary breast cancer and synchronous axillary lymph node metastasis. Med Oncol 2014
  8. doi: 10.1007/s12032-013-0798-y 8. Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer
  9. a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 1957
  10. Ostrowski JL, Sawan A, Henry L, et al. p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study. J Pathol 1991
  11. Mahler-Araujo B, Savage K, Parry S, Reis-Filho JS. Reduction of E-cadherin expression is associated with non-lobular breast carcinomas of basal-like and triple negative phenotype. J Clin Pathol 2008
  12. doi:10.1136/jcp.2007.053991. 11. Frickea E, Hermannstadtera C, Kellera G, et al. Effect of wild-type and mutant E-cadherin on cell proliferation and responsiveness to the chemotherapeutic agents Cisplatin, Etoposide, and 5-Fluorouracil. Oncology 2004
  13. doi: 10.1159/000077442 12. Bukholm IK, Nesland